Who is sponsoring NCT05072665?

NCT05072665 is sponsored by Clinique du Trocadéro.

What drugs are being tested in NCT05072665?

Interventions in NCT05072665: HIGH ECHOENDOSCOPY WITH THE FAST PROCEDURE.

What condition does NCT05072665 study?

NCT05072665 studies Food Allergy.

Is NCT05072665 still recruiting?

NCT05072665 is currently completed. Last updated 28 September 2023.

Last reviewed 2023-09-28 · How we verify

NCT05072665: FAST

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fast Allergy Sensitivity Test

Completed NA Last updated 28 September 2023

What this trial tests

NA trial testing HIGH ECHOENDOSCOPY WITH THE FAST PROCEDURE in Food Allergy in 40 participants. Completed in 4 May 2023.

Timeline

1 September 2021

Primary endpoint
1 April 2023

4 May 2023

Quick facts

Lead sponsor	Clinique du Trocadéro
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	40
Start date	1 September 2021
Primary completion	1 April 2023
Estimated completion	4 May 2023
Sites	1 location across France

Drugs / interventions tested

HIGH ECHOENDOSCOPY WITH THE FAST PROCEDURE

Conditions studied

Food Allergy — all drugs for Food Allergy →

Sponsor

Clinique du Trocadéro

Who can join

18 and older, any sex, with Food Allergy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Irritable Bowel Syndrome (IBS), or functional colopathy, is a chronic disease that affects 10% to 20% of the world's population.This syndrome is characterized by chronic abdominal pain or discomfort as well as a change in bowel habits (constipation or diarrhea) in the absence of structural or metabolic abnormalities (e.g. celiac disease, Crohn's disease). These symptoms have an impact on the quality of life of these patients who must therefore integrate the management of their disease into their daily life.IBS is subdivided into 3 subtypes according to the predominant symptom: the IBS-D subtype which groups together patients who have a predominance of diarrheal episodes, the IBS-C subtype which groups together patients who have a predominance of '' episodes of constipation and finally the IBS-M subtype which includes patients whose two symptoms mentioned above are observed without predominance

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of Food Allergens on the Duodenal Mucosa Visualized by Probe Based-Confocal Laser Endomicroscopy
Canard J, Dalu a, BENKESSOU B. · · 2025 · DOI 10.21203/rs.3.rs-6513299/v1

Verify or expand the search:

Other recruiting trials for Food Allergy

Currently open trials in the same condition.

NCT07210320 — PK/PD Study of IN-001 Sublingual Spray in Healthy Adults · Phase 1 · recruiting
NCT06943534 — Omalizumab Weight-Based Dosing Efficacy Trial · Phase 2 · recruiting
NCT06872996 — Trophallergen Prick Tests (PT) : Influence of Food Sample Shelf Life on the Reproducibility of PT Results · NA · recruiting
NCT06529913 — Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases · NA · recruiting
NCT06558526 — Pectin Intervention Study and Long-term Follow-up in Lipid Transfer Proteins Allergic Patients · NA · recruiting

Other Clinique du Trocadéro trials

Trials by the same sponsor.

NCT05072067 — EFFICACY OF THE SLEEVE GASTROPLASTY WITH THE ENDOSCOPIC SYSTEM OVERSTICH SX ON WEIGHT LOSS AND REDUCTION OF CO-MORBIDITY · NA · completed
NCT03758872 — CUFF-assisted Colonoscopy vs Standard Colonoscopy · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05072665 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Clinique du Trocadéro
Last refreshed: 28 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05072665.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing